SEC Tracker
Get the app

Actuate Therapeutics ACTU

Actuate Therapeutics sells 30,985,900 shares

Securities offering

Form
424B5
Filed
Importance
Routine
  1. Selling 30,985,900 shares of common stock and 15,492,950 warrants
  2. Each warrant allows purchase of one share at $0.45
  3. Offering price is $0.71 per two shares and warrant
  4. Underwriter has option to buy more shares and warrants

Written from the 424B5 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Actuate Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Lite Strategy LITS public float $43M, Dec 31, 2025
  2. Actinium Pharmaceuticals ATNM public float $44M, Jun 30, 2025
  3. Fortress Biotech FBIO public float $44M, Jun 30, 2025
  4. CervoMed CRVO public float $40M, Jun 30, 2025
  5. Acumen Pharmaceuticals ABOS public float $45M, Jun 30, 2025